The American journal of cardiology
Audio Summaries

Cardiac Magnetic Resonance for the Prediction of Arrhythmic Events in Mitral Valve Prolapse: A Systematic Review and Meta-analysis

May 10, 2026

This systematic review and meta-analysis aimed to evaluate the prognostic value of cardiac magnetic resonance (CMR) imaging biomarkers—late gadolinium enhancement (LGE), mitral annular disjunction (MAD), and systolic curling—in predicting arrhythmic events in patients with mitral valve prolapse (MVP). The findings indicated that all three biomarkers were significantly associated with an increased risk of arrhythmias, with LGE showing the best predictive performance. The study highlights the potential of CMR in risk stratification for MVP patients, suggesting a need for further research on management strategies for those with LGE.

"Mechanisms, Magnitude, and Consequence of Acute Estimated Glomerular Filtration Rate Change with Guideline-Directed Medical Therapy Initiation in Heart Failure"

May 10, 2026

The authors investigate the mechanisms and implications of acute changes in estimated glomerular filtration rate (eGFR) following the initiation of guideline-directed medical therapy (GDMT) in heart failure patients. They highlight that while GDMT can initially cause a transient decrease in eGFR, its long-term use is associated with a slower decline in kidney function and reduced risk of chronic kidney disease. The review emphasizes the importance of collaboration between nephrologists and cardiologists to monitor eGFR changes effectively and implement strategies to optimize the benefits of GDMT.

Confidence-Accuracy Alignment in Cardiology Knowledge: Comparing Medical-Specific and General-Purpose Large Language Models Using ACCSAP

May 9, 2026

The authors investigate whether medical-specific large language models (LLMs) provide improved clinical reliability compared to general-purpose models in cardiology knowledge assessment. Using a standardized benchmark, they found that general-purpose models like Gemini and ChatGPT outperformed the medical-specific model MedGemma in diagnostic accuracy, although all models exhibited poor confidence calibration. The study concludes that while general-purpose LLMs may excel in complex clinical reasoning, their self-reported confidence is not a reliable indicator of correctness, suggesting a need for clinician oversight in their use.

Transcatheter Tricuspid Valve Intervention Versus Optimal Medical Therapy in Symptomatic Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized and Observational Studies

May 8, 2026

The authors aimed to compare the clinical outcomes of transcatheter tricuspid valve intervention (TTVI) versus optimal medical therapy (OMT) in patients with symptomatic tricuspid regurgitation (TR). Their systematic review and meta-analysis of 13 studies found that TTVI was associated with reduced all-cause mortality compared to OMT, although this benefit was not confirmed in analyses restricted to randomized controlled trials. The findings suggest that TTVI may be a viable treatment option for high-risk patients with symptomatic TR, but caution is warranted due to potential confounding in non-randomized studies.

Impact of a VAD Optimization Clinic on Medication Utilization and Clinical Outcomes Following Left Ventricular Assist Device Implantation

May 8, 2026

The authors aimed to evaluate the impact of a 12-week VAD optimization clinic on medication utilization and clinical outcomes in patients following left ventricular assist device (LVAD) implantation. They found that participation in the clinic significantly increased the use of neurohormonal antagonists and reduced the incidence of recurrent hospitalizations compared to a control group, suggesting potential improvements in patient outcomes. The study highlights the need for further randomized trials to fully understand the effects of NHA optimization on post-LVAD outcomes.

Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Obesity Without Diabetes

May 8, 2026

This study aimed to evaluate the real-world cardiovascular outcomes of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with atherosclerotic cardiovascular disease (ASCVD) and obesity without diabetes. The findings indicated that GLP-1 RA use was associated with reduced all-cause mortality, acute myocardial infarction, and heart failure hospitalization, aligning with results from the SELECT trial, although no significant effect on stroke was observed. The authors emphasize that while their observational data support the benefits of GLP-1 RAs, causal conclusions cannot be drawn.

Long-Term Clopidogrel versus Aspirin Monotherapy After Drug-Eluting Stent Implantation: A Nationwide Real-World Comparative Study

May 8, 2026

The authors aimed to compare the long-term efficacy and safety of clopidogrel versus aspirin monotherapy in patients who underwent drug-eluting stent implantation and remained event-free for three years. In a nationwide cohort study involving 18,168 matched patients, they found no significant differences in the primary composite endpoint of all-cause death, myocardial infarction, ischemic stroke, and major bleeding between the two groups, although clopidogrel was associated with a lower risk of myocardial infarction. Overall, both antiplatelet strategies demonstrated comparable outcomes during the chronic maintenance phase over a follow-up of up to 10 years.

Severe Low Flow Aortic Stenosis with Preserved Ejection Fraction: Latest Diagnostic and Therapeutic Approach

May 7, 2026

This review addresses the complexities of diagnosing and managing paradoxical low-flow, low-gradient aortic stenosis (pLF-LG AS), a condition characterized by severe aortic stenosis with preserved ejection fraction. The authors emphasize the need for a comprehensive diagnostic approach and highlight the importance of individualized treatment strategies, including aortic valve replacement and transcatheter aortic valve implantation, to improve patient outcomes. They aim to clarify the distinctions between true-severe and pseudo-severe disease and the implications for clinical management.

Lipoprotein(a) Distribution Across Race/Ethnicity and Association with Mortality Outcomes in NHANES III (1988-1994) with Follow‑Up to 2019

May 7, 2026

This study investigates how the association between lipoprotein(a) [Lp(a)] levels and mortality outcomes varies across different race/ethnicity groups in a multi-ethnic cohort of U.S. adults from NHANES III. The authors found that Lp(a) concentrations were highest in non-Hispanic Black participants, and while higher Lp(a) levels were linked to increased cardiovascular mortality in Mexican Americans, this association was not observed in non-Hispanic White participants. The findings suggest the need for race/ethnicity-specific Lp(a) risk thresholds to improve cardiovascular risk stratification.

Obesity-Related Hypertension: An Emerging Clinical Phenotype

May 7, 2026

The authors investigate the emerging clinical phenotype of obesity-related hypertension, aiming to understand its distinct pathophysiological mechanisms and the associated cardiovascular risks. They highlight how the combination of obesity and hypertension exacerbates various cardiovascular complications, including left ventricular hypertrophy and chronic heart failure. The paper seeks to provide a comprehensive overview of the clinical implications and potential therapeutic approaches for managing this condition.